Medicare Enrolled
Dr. Vijay Ramanath, M.D.
Cardiovascular Disease · Plano, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ramanath from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ramanath? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ramanath
Dr. Vijay Ramanath is a cardiovascular disease in Plano, TX, with 19 years in practice. Based on federal Medicare data, Dr. Ramanath performed 3,661 Medicare services across 2,505 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ramanath received a total of $101,657 from 73 pharmaceutical and/or device companies across 1108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ramanath is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 27% volume in TX$ $101,657 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,661
Medicare services
Top 27% in TX for cardiovascular disease
2,505
Unique beneficiaries
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~193 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 641 | $90 | $220 |
| Hospital follow-up visit, high complexity | 581 | $93 | $234 |
| Electrocardiogram (EKG), 12-lead | 526 | $10 | $47 |
| Hospital follow-up visit, moderate complexity | 252 | $60 | $150 |
| Regadenoson injection (Lexiscan) for heart stress test | 176 | $42 | $150 |
| Echocardiogram, transthoracic | 161 | $140 | $800 |
| New patient office visit (45-59 min) | 151 | $116 | $335 |
| Initial hospital admission, high complexity | 87 | $134 | $410 |
| EKG interpretation and report | 85 | $6 | $40 |
| Initial hospital admission, moderate complexity | 80 | $99 | $280 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 72 | $10 | $25 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 68 | $170 | $800 |
| Heart muscle strain imaging | 68 | $29 | $82 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 67 | $145 | $520 |
| Ultrasound of heart blood flow, valves and chambers | 63 | $39 | $190 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 63 | $18 | $190 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 62 | $92 | $350 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 46 | $49 | $190 |
| Laser destruction of incompetent vein of arm or leg using imaging guidance | 41 | $753 | $2,930 |
| Office visit, established patient (20-29 min) | 41 | $62 | $150 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 40 | $334 | $2,500 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 39 | $34 | $400 |
| Cardiac catheterization | 35 | $178 | $1,057 |
| Critical care, first 30-74 min | 29 | $161 | $560 |
| Ultrasound of both sides of head and neck blood flow | 28 | $146 | $510 |
| Ultrasound of heart with probe in esophagus, with report | 25 | $83 | $275 |
| Ultrasound of leg arteries or artery grafts | 22 | $180 | $820 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 21 | $1,290 | $4,400 |
| Ultrasound of one leg arteries or artery grafts | 21 | $86 | $820 |
| Ct scan of blood vessels and grafts of heart with contrast | 19 | $89 | $245 |
| Coronary stent placement | 14 | $434 | $3,000 |
| Ultrasound study of arm and leg arteries | 14 | $58 | $820 |
| Ultrasound of heart, follow-up | 12 | $19 | $205 |
| New patient office visit (30-44 min) | 11 | $79 | $220 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.2% high complexity
19.9% medium
70.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$101,657
Total received (2018-2024)
Avg $14,522/year across 7 years
Top 6% in TX for cardiovascular disease
73
Companies
1,108
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$47,220 (46.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$30,407 (29.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$18,825 (18.5%)
Other
Charitable contributions, space rental, and other categories
$5,205 (5.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$16,762
2023$4,324
2022$9,733
2021$7,863
2020$8,675
2019$36,833
2018$17,467
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$23,813
Medtronic Vascular, Inc.
$10,363
BOSTON SCIENTIFIC CORPORATION
$8,550
Terumo Medical Corporation
$7,984
Penumbra, Inc.
$7,652
Cardiovascular Systems Inc.
$6,453
Medtronic, Inc.
$6,068
AngioDynamics, Inc.
$5,601
Edwards Lifesciences Corporation
$3,633
Shockwave Medical, Inc
$3,220
Janssen Pharmaceuticals, Inc
$1,736
Abbott Laboratories
$1,616
W. L. Gore & Associates, Inc.
$1,517
Novartis Pharmaceuticals Corporation
$1,250
Amgen Inc.
$1,248
PFIZER INC.
$758
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$687
HeartFlow, Inc.
$644
ABIOMED
$623
AstraZeneca Pharmaceuticals LP
$615
E.R. Squibb & Sons, L.L.C.
$583
Boehringer Ingelheim Pharmaceuticals, Inc.
$554
Medicure Pharma Inc.
$480
Merck Sharp & Dohme LLC
$473
Amarin Pharma Inc.
$426
Lundbeck LLC
$399
Itamar Medical Inc
$350
Philips Electronics North America Corporation
$342
SANOFI-AVENTIS U.S. LLC
$335
Alnylam Pharmaceuticals Inc.
$334
GENZYME CORPORATION
$318
Esperion Therapeutics, Inc.
$280
Cleerly, Inc.
$273
Regeneron Healthcare Solutions, Inc.
$267
Astellas Pharma US Inc
$220
Chiesi USA, Inc.
$209
Merck Sharp & Dohme Corporation
$188
Inari Medical, Inc.
$182
Tactile Systems Technology Inc
$134
Recor Medical Inc
$131
Gilead Sciences, Inc.
$114
Kiniksa Pharmaceuticals International, plc
$78
Kowa Pharmaceuticals America, Inc.
$77
Cardiac Assist, Inc.
$72
BARD PERIPHERAL VASCULAR, INC.
$65
ARBOR PHARMACEUTICALS, INC.
$64
ShockWave Medical, Inc
$62
SCPHARMACEUTICALS INC.
$61
CVRx, Inc.
$53
Baxter Healthcare
$40
Althera Pharmaceuticals LLC
$39
Novo Nordisk Inc
$39
G Medical Diagnostic Services, Inc.
$28
Arbor Pharmaceuticals, Inc.
$27
Bardy Diagnostics, Inc.
$26
Bard Peripheral Vascular, Inc.
$26
Actelion Pharmaceuticals US, Inc.
$23
Lexicon Pharmaceuticals, Inc.
$23
ATRICURE, INC.
$20
Medline Industries, Inc.
$19
Azurity Pharmaceuticals, Inc.
$17
CHIESI USA, INC.
$17
Kiniksa Pharmaceuticals, Ltd.
$17
MEDICOMP INC
$16
CashFlow Solutions, LLC
$16
Inspire Medical Systems, Inc.
$15
Amicus Therapeutics, Inc.
$15
Allergan Inc.
$14
Surmodics, Inc.
$14
Otsuka America Pharmaceutical, Inc.
$14
Intact Vascular, Inc.
$14
Cardinal Health 200, LLC
$13
CORDIS US CORP.
$13
Top 3 companies account for 42.0% of total payments
Associated products mentioned in payments ›
(6554) Periph Vasc Undiv · (6582) Visions 035 · (6585) Omniwire · (9281) Turbo Elite · 3F · ALPHAVAC · AMPLATZER TALISMAN · ANGIOJET · ASSURITY · AURYON LASER SYSTEM 100-120 VAC · AVVIGO Guidance System · Abre · AngioVac · Arcalyst · Auryon Laser System 100-120 Vac · BRILINTA · BYSTOLIC · Barostim Neo System · Biofreedom (DES) · CAMZYOS · CARDENE · CARDIOFORM Septal Occluder · CARDIOMEMS · CHANTIX · COBALT DR MRI SURESCAN · CONFIRM RX · COREVALVE EVOLUT R · CROSSBOSS · CROSSER · Cardiac Monitor · Cardiac Monitoring Suite · CardioMEMS HF System · Carnation Ambulatory Monitor · Cleerly Ischemia · Cleerly Labs · Confirm Rx · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · EDARBYCLOR · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ELUVIA · ENSITE · ENTRESTO · ESPRIT · EXCLUDER AAA Endoprosthesis · EXCLUDER Iliac Branch Endoprosthesis · Edarbi · Edarbyclor · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Evera · FABRAZYME · FABRY-DISEASE · FARXIGA · FFRct · FLEXITOUCH · FLOWTRIEVER CATHETER · FUROSCIX · Flexitouch Plus · GENERAL BALLOONS · GENERAL GUIDEWIRES · GENERAL GUIDEWIRES · GENERAL STRUCTURAL HEART · GENERAL THERAPIES · GENERAL VASCULAR INTERVENTION · GENERAL METALLIC STENTS · GENERAL NONVASCULAR INTERVENTION · GENERAL THERAPIES · GENERAL VASCULAR INTERVENTION · General - Therapies · General - Vascular Intervention · GlideWire · Glidesheath · HMG-CoA reductase inhibitor. · HawkOne · HeartMate 3 Left Ventricular Assist Device · Hillrom - Carnation Ambulatory Monitor · Hyalomatrix Wound Device · IGT D Peripheral · IGT_D Peripheral · INSPIRE · Impella · Indigo · Indigo System · Inpefa · JARDIANCE · JETSTREAM · JUDO 3 · KENGREAL · KENGREAL 50MG/10ML L · LEQVIO · LEXISCAN · LINQ II · LOKELMA · LUTONIX · LYMPHA PRESS OPTIMAL PLUS(US) BT · LifeVest · Livalo · METACROSS OTW · MICRA · MITRACLIP · MULTAQ · Merlin Connectivity and Remote · MetaCross · Micra · MitraClip System · NEXLETOL · NORTHERA · ONPATTRO · ONYX FRONTIER · OPSUMIT · Optitorque · Ozempic · PARADISE RENAL DENERVATION SYSTEM · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PROMUS · Penumbra Ruby Coil · Penumbra System · Peripheral Orbital Atherectomy System · Pounce Venous Thrombectomy System · QT Vascular Chocolate PTA Balloon · Quadra Assura CRT Defibrillator · ROTABLATOR · Repatha · Resolute · Roszet · S · S.M.A.R.T. CONTROL · SAMSCA · SAPIEN 3 Ultra RESILIA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYNERGY · SYNERGY ABLATION SYSTEM · TAG Thoracic Endoprosthesis · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TR Band · Tack Endovascular System · TandemHeart · VENACURE 1470 PRO · VENASEAL · VERQUVO · VIABAHN VBX Balloon Expandable Endoprosthesis · VYNDAQEL · Vascepa · Vascular Lithotripsy · VenaCure 1470 Pro · VenaSeal · WATCHMAN · WatchPAT · WatchPATONE · XARELTO · XIENCE SKYPOINT · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (46%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for cardiovascular disease in TX.
Equivalent to $2,777 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
290
Per 100K population
26.0
County median income
$117,588
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ramanath is a clinical cardiology specialist, with above-average Medicare volume (top 27% in TX), and high industry engagement (mixed engagement, top 6%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ramanath experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ramanath performed 641 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ramanath receive payments from pharmaceutical companies?
Yes. Dr. Ramanath received a total of $101,657 from 73 companies across 1,108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ramanath's costs compare to other cardiovascular diseases in Plano?
Dr. Ramanath's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ramanath) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Plano
Browse cardiovascular diseases in Plano ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology